| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $43.0M | +3.9% |
| Cost of Revenue | $46.9M | +6.5% |
| R&D Expense | $54.9M | +19.8% |
| SG&A Expense | $55.3M | -10.6% |
| Operating Income | -$165.2M | -11.2% |
| Pre-tax Income | -$162.2M | +2.4% |
| Income Tax | $89K | +67.9% |
| Net Income | -$162.3M | +2.4% |
| EPS (Basic) | -$1.13 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $109.8M | -12.0% |
| Accounts Receivable | $7.0M | -72.6% |
| Inventory | $29.4M | +153.4% |
| Current Assets | $278.9M | -16.2% |
| Total Assets | $316.7M | -30.0% |
| Current Liabilities | $44.3M | +8.6% |
| Long-term Debt | $6.0M | — |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$135.2M | -27.8% |
| Capital Expenditures | $2.2M | +45.3% |
| Investing Cash Flow | $126.4M | +145.5% |
| Financing Cash Flow | -$6.0M | -101.3% |
| Free Cash Flow | -$137.5M | -28.0% |
| +41.1% |
| EPS (Diluted) | -$1.13 | +41.1% |
| Total Liabilities |
| $75.9M |
| +1.6% |
| Stockholders' Equity | $240.8M | -36.2% |